FDA 483 - Anesthetic Gas Reclamation Inc. - May 04, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Anesthetic Gas Reclamation Inc. in Dallas, TX, was cited with six observations during an FDA inspection regarding its manufacturing of Class 2 Dynamic Gas Scavenging System-2 (DGSS-2) devices. The inspection revealed significant deficiencies across multiple quality system areas, including finished device acceptance, supplier evaluation, equipment calibration, complaint handling, internal audits, and document control. These issues indicate a lack of adequate procedures and adherence to established quality management practices.
ID · f863c3f8-362b-4d77-90d3-99a275c50f66